Welcome to your 9. 🩻 Lung Malignancy & Cardiorespiratory Manifestations of Systemic Disease Arena — 40 Integrated MCQs
1.
A 68-year-old man with a newly diagnosed lung malignancy has disease confined to the lung without distant spread. Histology confirms a non-small-cell lung carcinoma, and cardiopulmonary assessment shows that he is fit for major treatment. Which management principle is most appropriate?
2.
A patient with systemic disease develops palpitations and episodes of syncope. Which cardiac structure should be considered if the manifestations result from electrical dysfunction?
3.
A patient with suspected bronchogenic carcinoma has already undergone chest imaging. What is the major purpose of obtaining tissue before definitive treatment?
4.
A patient with lung carcinoma develops progressive breathlessness. Imaging demonstrates a large malignant pleural effusion. Which process most directly accounts for the respiratory symptom?
5.
A 71-year-old man with pleural malignancy has recurrent unilateral effusion and increasing chest-wall pain. CT shows extensive pleural disease invading adjacent structures. Which interpretation is most appropriate?
6.
A patient with systemic disease develops progressive breathlessness. Pulmonary function testing demonstrates a reduction in lung expansion consistent with impaired compliance. Which physiological pattern is most likely?
7.
A patient with bronchogenic carcinoma develops new persistent hoarseness without an intrinsic laryngeal lesion. Which mechanism is the most likely explanation?
8.
A patient with systemic autoimmune disease has progressive exertional dyspnea. Chest imaging shows diffuse interstitial abnormalities, while pulmonary function testing demonstrates reduced lung volumes. Which interpretation best connects these findings?
9.
A 70-year-old retired construction worker presents with progressive dyspnea, chest pain and recurrent unilateral pleural effusion. Which diagnosis should be particularly suspected?
10.
A 62-year-old patient with an apical lung tumor develops severe shoulder pain radiating down the arm. Which mechanism best explains this presentation?
11.
A patient with suspected bronchogenic carcinoma has a central lung mass visible on CT. Which investigation is most appropriate for obtaining tissue from a centrally located endobronchial lesion?
12.
A 64-year-old man with a long smoking history presents with persistent cough, weight loss and intermittent hemoptysis. Chest imaging shows a suspicious hilar mass. Which broad category contains the majority of bronchogenic carcinomas other than small-cell carcinoma?
13.
A patient with systemic disease develops sudden worsening dyspnea and hypoxemia. The clinician suspects alveolar-capillary involvement rather than isolated airway disease. Which physiological consequence is most likely?
14.
A patient with a peripheral lung mass also has a large, easily accessible supraclavicular lymph node. Malignancy is strongly suspected. Which approach best reflects the diagnostic principle for obtaining tissue?
15.
A patient with a systemic inflammatory disease develops clinically significant pulmonary involvement. Which management principle is most appropriate?
16.
A 58-year-old man with lung carcinoma develops facial swelling, neck vein distension and breathlessness. Which complication best explains this presentation?
17.
A patient with systemic disease develops progressive exertional dyspnea, syncope and signs of right-heart strain. Which pulmonary complication should be considered?
18.
A patient with suspected pleural mesothelioma undergoes pleural fluid aspiration. Cytology does not establish the diagnosis, but CT continues to show diffuse pleural thickening. What is the most appropriate interpretation?
19.
A patient with bronchogenic carcinoma has completed tissue diagnosis and staging. Before deciding whether major surgery is appropriate, which additional factor is most important?
20.
A patient with a chronic systemic disorder develops exertional dyspnea, peripheral edema and impaired ventricular relaxation due to abnormal tissue deposition within the myocardium. Which type of systemic effect is most likely?
21.
A patient with squamous cell carcinoma of the lung develops weakness, constipation and hypercalcemia. Which tumor-related mechanism is most likely responsible?
22.
Two patients have the same systemic disease with pulmonary involvement. One has mild reversible abnormalities, while the other has progressive severe functional impairment. Which factor most directly explains why their prognosis may differ?
23.
A patient with systemic disease develops new dyspnea. The physician suspects interstitial pulmonary involvement. Which investigation is most useful for defining the structural pattern in greater detail?
24.
A patient with a systemic inflammatory disorder develops a new cardiac murmur and progressive exertional dyspnea. Echocardiography shows significant valvular dysfunction. Which relationship best explains the presentation?
25.
A patient with systemic disease has exertional dyspnea and reduced oxygen saturation. Chest radiography shows an abnormal diffuse pattern, but the mechanism remains unclear. Which next step best follows the investigation principle taught for systemic pulmonary involvement?
26.
A patient with suspected pleural mesothelioma has diffuse pleural thickening and recurrent pleural effusion. Which investigation is most important for establishing a definitive diagnosis?
27.
A patient with extensive pleural mesothelioma has progressive dyspnea, pain and declining functional status. Curative treatment is not feasible. Which management principle is most appropriate?
28.
A patient with a systemic autoimmune disease develops sharp chest pain and a new pericardial effusion. Which cardiovascular structure is primarily involved?
29.
A patient with lung malignancy develops confusion and laboratory evidence of hyponatremia due to inappropriate antidiuretic hormone activity. Which tumor type is most strongly associated with this finding?
30.
A patient with systemic disease develops dyspnea. Clinical assessment suggests possible cardiac and pulmonary involvement. Which approach best demonstrates integrated clinical reasoning?
31.
A patient with a neuromuscular systemic disorder develops shallow breathing and progressive ventilatory failure despite no major structural lung abnormality. What is the most likely mechanism?
32.
A patient with systemic disease develops new breathlessness. ECG shows no major abnormality, but echocardiography demonstrates reduced ventricular systolic function. What is the main significance of the echocardiographic finding?
33.
A patient with confirmed bronchogenic carcinoma undergoes additional imaging to assess lymph nodes and distant organs. What is the main purpose of this assessment?
34.
A patient with a systemic inflammatory disease develops exertional chest discomfort. Evaluation suggests inflammation and injury of the coronary circulation rather than primary airway disease. Which cardiovascular manifestation is most relevant?
35.
A patient with a systemic inflammatory disorder develops progressive dyspnea, peripheral edema and reduced ventricular function. Which form of cardiovascular involvement best explains these findings?
36.
A patient with systemic disease develops progressive exertional dyspnea and fine inspiratory crackles. Which pulmonary compartment is most likely affected?
37.
A patient with bronchogenic carcinoma develops recurrent pneumonia in the same lung segment. Which mechanism most directly explains this complication?
38.
A patient with confirmed small-cell lung carcinoma has no indication that the disease is confined to a surgically curable local lesion. Which therapeutic principle best reflects the biological behavior of this tumor?
39.
A patient with systemic disease develops pleuritic chest pain and a pleural effusion. Which pulmonary manifestation best accounts for these findings?
40.
A patient receiving treatment for a systemic inflammatory disease develops new cough and progressive breathlessness. Previous respiratory assessment was normal. Which principle should guide further evaluation?
